ASH President Emphasizes: A Call to Action for Hematology
ASH President Dr. Belinda R. Avalos emphasizes the Urgency of Advocacy in a Time of Scientific Retrenchment in her post shared on X:
“The President’s FY26 Budget cuts NIH funding by nearly 40%. This would halt critical hematology research progress. ASH urges Congress to reject these cuts and support sustained medical research funding. Read the full statement”
In her editorial “Stand Up and Be Counted” published in The Hematologist (2025; 22[3]), Dr. Belinda R. Avalos, President of the American Society of Hematology (ASH), delivers a powerful message: the time for scientific silence is over. Amid sweeping federal cuts to the NIH, CDC, and Medicaid, hematology stands at a critical juncture.
Dr. Avalos underscores that patient care and research in blood diseases are at risk, and calls on the hematology community to engage with policymakers, elevate patient stories, and protect the future of biomedical innovation. ASH continues to mobilize through coalition-building, advocacy campaigns, and its Fight 4 Hematology Action Hub.
Title: Stand Up and Be Counted
Author: Belinda R. Avalos
Read the full editorial on Hemostasis Today
Join the movement. Science needs your voice — now more than ever.
Visit the Fight4Hematology Action Hub to get involved.
-
Jun 13, 2025, 08:19Decoding the Inflammatory–Metabolic Axis in Atherosclerosis: A New Frontier in Cardiovascular Prevention- by Atherosclerosis
-
Jun 13, 2025, 08:07The Genetic Spectrum of Rare Bleeding Disorders by Flora Peyvandi and Samin Mohsenian
-
Jun 13, 2025, 07:58Managing Thrombosis in MPN: Emphasizing Early Intervention and Age-Based Care
-
Jun 12, 2025, 10:34Apply Now: HTRS Funding Opportunities for Aspiring Hemostasis Researchers
-
Jun 12, 2025, 10:33Review of Factor IX Replacement Therapy in Hemophilia B with CSL Behring on June 22
-
Jun 13, 2025, 07:543-Year Outcomes of AAV Gene Therapy in Hemophilia B: Study Published in NEJM Shows Long-Term Factor IX Expression
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Jun 7, 2025, 08:46David Smadja: A Major Step Forward in The Fight Against Cancer-Related Thrombosis
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation